Diadem Biotherapeutics
Pre-clinicalDiadem Biotherapeutics engineers first-in-class extracellular vesicles to target and treat cancer, chronic inflammatory and autoimmune conditions.
Founded
2018
Focus
Drug Delivery
About
Diadem Biotherapeutics engineers first-in-class extracellular vesicles to target and treat cancer, chronic inflammatory and autoimmune conditions.
Funding History
1Total raised: $12M
Series A$12MUndisclosedMar 15, 2023
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile